Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Ensem Therapeutics
AstraZeneca
Mayo Clinic
Kivu Bioscience Inc.
AstraZeneca
Tubulis GmbH
Eli Lilly and Company
Arcus Biosciences, Inc.
Sumitomo Pharma America, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Radiopharm Theranostics, Ltd
Seagen Inc.
Bayer
Radiopharm Theranostics, Ltd
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Exscientia AI Limited
Normunity AccelCo, Inc.
Eli Lilly and Company
Poseida Therapeutics, Inc.
Baylor College of Medicine
MacroGenics
SystImmune Inc.
City of Hope Medical Center
Boundless Bio, Inc.
Eli Lilly and Company
AbbVie
Radiopharm Theranostics, Ltd
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Innate Pharma
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Brigham and Women's Hospital
Jacobio Pharmaceuticals Co., Ltd.
Var2 Pharmaceuticals
OncoNano Medicine, Inc.
GlaxoSmithKline
Fate Therapeutics
Compass Therapeutics
Tanabe Pharma America, Inc.
NeoTX Therapeutics Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
Pfizer
OncoHost Ltd.
BicycleTx Limited
Volastra Therapeutics, Inc.